Check out what Forbes said about Gardisil
This may sound like an odd place to read up on something like this, but check out Forbes magazine. They had an article earlier this year, recommending against investing in the manufacturer. The reasons included the possiblity of a number of lawsuits, questions as to the actual effectiveness, possible side effects and that the vaccine addresses only a few of the 15 viruses which are possible causes. The fact that a major financial publication is recommending against this as an investment certainly gave me pause.
|